SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-054483
Filing Date
2021-04-23
Accepted
2021-04-23 16:31:17
Documents
5
Period of Report
2021-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2113410-2_def14a.htm DEF 14A 501880
2 GRAPHIC lg_markertherapeutics-4clr.jpg GRAPHIC 57435
3 GRAPHIC sg_michael-4c.jpg GRAPHIC 6437
4 GRAPHIC tm2113410d2-proxy_markpg1bw.jpg GRAPHIC 945782
5 GRAPHIC tm2113410d2-proxy_markpg2bw.jpg GRAPHIC 1022947
  Complete submission text file 0001104659-21-054483.txt   3299280
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37939 | Film No.: 21850232
SIC: 2834 Pharmaceutical Preparations